Stem Cell Population Safety via Hypoxic Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Pluripotent stem cells, such as embryonic stem cells, pose a risk of tumor formation when used in vivo due to their ability to generate teratomas, and existing methods fail to effectively reduce the number of residual stem cells in differentiated cell populations, limiting their therapeutic and in vitro applications.
Innovation Solution
Exposing differentiated cell populations to low oxygen partial pressures for extended periods reduces the number of residual pluripotent stem cells without compromising the quality or function of the differentiated cells, thereby minimizing the risk of tumor formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If differentiated cell populations are used for in vivo administration, then therapeutic potential is improved, but risk of tumor formation increases due to residual pluripotent stem cells
Solution Approach 1:
The patent changes the oxygen partial pressure parameter from normoxic (20% O2) to hypoxic conditions (5% O2) during extended culture. This parameter change selectively reduces residual pluripotent stem cells while preserving differentiated cell function, thereby reducing tumor formation risk without compromising therapeutic potential
Solution Approach 2:
The patent applies hypoxic treatment before in vivo administration to pre-reduce the number of residual pluripotent stem cells. This preliminary action eliminates tumor-forming cells in advance, ensuring safer transplantation without affecting the therapeutic efficacy of differentiated cells
2Quantity of substance
If extended culture at low oxygen partial pressure is applied, then frequency of pluripotent stem cells decreases, but culture time increases
Solution Approach 1:
By changing the oxygen partial pressure parameter to hypoxic conditions (5% O2), the patent accelerates the reduction of pluripotent stem cells. Extended culture under these specific conditions achieves greater than 100-fold reduction in stem cell frequency, making the time investment worthwhile for safety
Solution Approach 2:
The patent converts the potential harm of extended culture time into a benefit by using that extended period under hypoxic conditions to selectively eliminate residual stem cells. The extended time allows thorough reduction of tumor-forming cells while preserving differentiated cell function
3Quantity of substance
If extended culture at low oxygen partial pressure is applied, then residual stem cells are reduced, but effect on differentiated cell quality must be minimized
Solution Approach 1:
The patent creates different microenvironmental conditions (hypoxic at 5% O2) that selectively affect residual stem cells differently from differentiated cells. This local quality difference in oxygen sensitivity allows selective reduction of stem cells while preserving differentiated cell function and quality
Solution Approach 2:
The patent uses parameter changes (oxygen partial pressure, culture duration) to achieve selective effects. Extended culture at 5% O2 specifically reduces stem cells while the differentiated cells maintain their quality and function, as evidenced by their continued suitability for therapeutic use
Data Source
AI summary
The invention provides methods and compositions relating to differentiated cell populations that derive from pluripotent stem cells. The methods relate to reducing the number of residual stem cells present in such populations. The compositions include differentiated cell populations that contain reduced number of stem cells or that contain no stem cells. Pluripotent stem cells may be reduced in number and/or function through exposure to low oxygen levels.